Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
CALL
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.66B
| $4.84M | ﹤0.01% |
268,500
+122,700
| +84% | +$2.33M |
|
3752
Corcept Therapeutics
CORT
$12.4B
| $4.84M | ﹤0.01% |
203,667
-7,566
| -4% | -$165K |
|
3753
PUT
Albertsons Companies
ACI
$6.03B
| $4.84M | ﹤0.01% |
181,200
-109,000
| -38% | -$3.34M |
|
3754
Avantis International Equity ETF
AVDE
$18.8B
| $4.84M | ﹤0.01% |
95,023
+79,091
| +496% | +$4.44M |
|
3755
CALL
ArcBest
ARCB
$3.19B
| $4.84M | ﹤0.01% |
68,800
+2,100
| +3% | +$154K |
|
3756
Grid Dynamics Holdings
GDYN
$629M
| $4.84M | ﹤0.01% |
287,597
+153,576
| +115% | +$2.51M |
|
3757
PUT
Kinross Gold
KGC
$32.4B
| $4.84M | ﹤0.01% |
1,351,200
-632,500
| -32% | -$3.06M |
|
3758
PUT
Direxion Daily Energy Bull 2X ETF
ERX
$251M
| $4.83M | ﹤0.01% |
103,000
-53,400
| -34% | -$3.22M |
|
3759
CALL
MBIA
MBI
$264M
| $4.83M | ﹤0.01% |
391,500
-1,400
| -0.4% | -$18.4K |
|
3760
WisdomTree Dynamic International Equity Fund
DDWM
$1.51B
| $4.83M | ﹤0.01% |
172,865
+128,770
| +292% | +$3.85M |
|
|
PLL
3761
CALL
DELISTED
Piedmont Lithium
PLL
| $4.83M | ﹤0.01% |
132,700
+29,000
| +28% | +$1.72M |
|
3762
iShares MSCI USA Value Factor ETF
VLUE
$9.78B
| $4.83M | ﹤0.01% |
53,346
-112,444
| -68% | -$11.1M |
|
3763
PUT
iShares MBS ETF
MBB
$39.1B
| $4.83M | ﹤0.01% |
49,500
+3,700
| +8% | +$363K |
|
3764
PUT
Magna International
MGA
$18.8B
| $4.83M | ﹤0.01% |
87,900
-48,200
| -35% | -$2.94M |
|
3765
CALL
American Eagle Outfitters
AEO
$2.71B
| $4.83M | ﹤0.01% |
431,600
+73,300
| +20% | +$1.03M |
|
3766
PUT
Fluor
FLR
$7B
| $4.82M | ﹤0.01% |
198,200
-25,900
| -12% | -$696K |
|
3767
CALL
Amylyx Pharmaceuticals
AMLX
$2.41B
| $4.82M | ﹤0.01% |
+250,300
| New | +$2.97M |
|
|
COHR
3768
CALL
DELISTED
Coherent Inc
COHR
| $4.82M | ﹤0.01% |
18,100
+17,300
| +2,163% | +$4.64M |
|
3769
PUT
FirstService
FSV
$6.18B
| $4.81M | ﹤0.01% |
39,700
+38,300
| +2,736% | +$4.83M |
|
3770
FirstCash
FCFS
$9.31B
| $4.81M | ﹤0.01% |
69,185
+16,495
| +31% | +$1.19M |
|
3771
SK Telecom
SKM
$14.8B
| $4.81M | ﹤0.01% |
215,400
+116,828
| +119% | +$2.95M |
|
|
QVCGA
3772
PUT
DELISTED
QVC Group Inc Series A
QVCGA
| $4.81M | ﹤0.01% |
33,508
+30,268
| +934% | +$5.88M |
|
3773
CALL
Xerox
XRX
$407M
| $4.81M | ﹤0.01% |
323,700
+98,200
| +44% | +$1.74M |
|
3774
PUT
Penumbra
PEN
$12.9B
| $4.79M | ﹤0.01% |
38,500
+20,600
| +115% | +$3.27M |
|
3775
FerroAtlántica
GSM
$820M
| $4.79M | ﹤0.01% |
806,239
+618,335
| +329% | +$4.34M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.